How to Value a Veterinary Practice in 2026

Valuing a veterinary practice in 2026 is a two-track exercise: one track for private buyers (individual veterinarians or small groups buying with SBA financing) and one track for corporate consolidators (Mars/VCA, Thrive, NVA, Pathway, and dozens of regional PE-backed platforms). The same practice can get a radically different offer from each pool — sometimes 2x to 3x apart — so understanding which buyer you are selling to is just as important as the underlying numbers. This guide walks through the full methodology an experienced M&A advisor uses, including how to normalize EBITDA, benchmark multiples, and structure deals that actually close in 2026.

What Valuing a Veterinary Practice Requires

Two inputs drive every vet practice valuation: a clean earnings figure and the right multiple. The earnings figure is either SDE (for smaller owner-operated practices) or normalized EBITDA (for larger practices with associate coverage). SDE includes the owner's compensation and is the right metric when the buyer is stepping into the owner's role. EBITDA strips out a market-rate owner's salary and is the right metric when the buyer — usually a consolidator — will install a paid practice manager and keep the owner on as a clinical DVM.

Normalization is where most valuations go wrong. Common add-backs include owner compensation above market (typically $180K-$220K for a full-time owner-DVM depending on region), personal auto, CE travel, family members on payroll who do not work, one-time equipment purchases, and COVID-era PPP forgiveness. For the full add-back methodology, see our guide on how to calculate add-backs for a business sale.

The Five Levers That Move Your Multiple

Five factors determine which end of the multiple range you land on. Practice size is the biggest — below $500K EBITDA you are in private-buyer territory (3x-5x SDE), between $500K-$1M you start seeing small consolidator interest (5x-8x), and above $1M EBITDA you are a platform target with multiple bidders (8x-12x+). Associate coverage matters second — a practice where the owner personally generates less than 40% of revenue trades at a meaningful premium because it actually transfers. Revenue mix favors surgery, dentistry, and diagnostics over wellness and boarding. Location matters for consolidators, who pay up for dense metropolitan markets with steady pet ownership growth. Specialty and ER practices trade at 10x-15x EBITDA — meaningfully higher than general practice.

A Concrete Example

Consider a three-DVM general practice in a suburban market with $4.2M revenue, $950K normalized EBITDA (23% margin), 60% associate-produced revenue, modern equipment, and a 10-year track record. Base EBITDA multiple for a practice this size: 8x-10x from a consolidator, so $7.6M-$9.5M for the practice itself. Real estate (if owned) at roughly $1.6M depending on the market, priced separately on a 7% cap. Total package to the seller: $9M-$11M, typically 75%-80% cash at close, 15%-20% rollover equity in the acquirer's platform, and a 2-year employment commitment for the selling DVM at fair market compensation.

Compare that to the same $4.2M revenue practice where the owner-DVM personally produces 75% of the revenue, EBITDA is only $600K (14% margin), and equipment needs replacement. Consolidators will either pass entirely or offer 5x-6x EBITDA ($3M-$3.6M) with heavy earnout and long seller retention requirements. Same revenue. Roughly a third of the value. The difference is transferability.

Comparison to Other Valuation Approaches

Pure revenue multiples are common in industry chatter ("my practice is worth 1x revenue") but they are a sanity check, not a valuation method. A 22%-margin practice and a 12%-margin practice cannot both be worth 1x revenue. The EBITDA multiple approach captures profitability differences that revenue multiples hide. DCF models get used on larger multi-location platforms but are rarely the primary method for a single clinic. For the full comparison of methods, see our complete guide to business valuation methods.

One method that shows up specifically in vet practice sales is the asset-plus-goodwill approach, where a buyer pays book value for equipment and inventory plus a separate goodwill figure. This is mostly used in smaller private-buyer transactions under $500K EBITDA and is really just an EBITDA-derived number dressed up differently. Consolidators almost always use EBITDA multiples directly.

Valuation Impact: What to Fix Before You Sell

If you have 18-36 months before a sale, three changes move the needle most. First, hire an additional associate and transition client relationships so owner-produced revenue drops below 50%. This alone can shift you from a 6x multiple to an 8x multiple. Second, lean into higher-margin services — dentistry and surgery capacity adds directly to EBITDA. Third, clean up the books. Consolidators run a full Quality of Earnings review and any messy financials, commingled personal expenses, or undocumented add-backs create deductions the buyer will take from the price.

Real estate decisions deserve their own thought. If you own the building, most consolidators will want a long-term NNN lease (10-15 years) at market rent. That rent becomes a deduction from EBITDA, which affects the practice multiple. Some sellers sell the building to a healthcare REIT for a 6%-7% cap, some hold it as passive income. Modeling both paths is part of a real exit planning process.

Exit Implications

The buyer you target depends on your size and goals. Private buyers (individual DVMs, small local groups) typically buy practices with under $500K EBITDA using SBA 7(a) loans. Deals close in 90-120 days, structures are simple (mostly cash at close), and multiples are lower. Consolidators typically target practices above $750K EBITDA and compete hardest above $1M. They pay higher multiples but with more complex structures — rollover equity, earnouts, longer seller retention commitments, and post-close integration expectations.

Timeline is roughly 4-9 months for a consolidator deal from first contact to close, versus 3-5 months for a private buyer. Consolidators will always run a Quality of Earnings analysis and a detailed operational diligence covering staffing, compliance, DEA records, and client retention metrics — see what happens during business sale due diligence for the full playbook. The companion post, What Is a Veterinary Practice Worth?, has a faster overview of typical ranges.

Whatever path you choose, model the outcome against your personal financial target before you sign anything. YourExitValue lets you run corporate and private buyer scenarios side by side, adjust for rollover equity and earnouts, and see your actual walk-away number after taxes. Start with the veterinary industry hub or the valuation calculator to benchmark your practice today.